ERBB2 and gastric cancer: In this study, we employed the human gastric cancer cell NCI-N87 with high expression of Her-2 protein to create a trastuzumab-resistant cell line (NCI-N87/TR) for the first time, analyzed the characteristics of NCI-N87/TR cells and investigated the detailed mechanisms regulating the in vitro resistance of gastric cancer to trastuzumab.